Patent | Date |
---|
Breast And Ovarian Cancer Vaccines App 20220040275 - DISIS; Mary L. ;   et al. | 2022-02-10 |
Breast and ovarian cancer vaccines Grant 11,185,578 - Disis , et al. November 30, 2 | 2021-11-30 |
Breast And Ovarian Cancer Vaccines App 20210346480 - DISIS; Mary L. ;   et al. | 2021-11-11 |
Breast and ovarian cancer vaccines Grant 11,160,853 - Disis , et al. November 2, 2 | 2021-11-02 |
Cancer vaccine compositions and methods of use thereof Grant 10,759,836 - Disis , et al. Sep | 2020-09-01 |
Methods And Materials For Expanding Antigen-specific T Cells In Culture App 20200248140 - Kind Code | 2020-08-06 |
Methods and materials for expanding antigen-specific T cells in culture Grant 10,647,961 - Cohen , et al. | 2020-05-12 |
Breast And Ovarian Cancer Vaccines App 20200054725 - Disis; Mary L. ;   et al. | 2020-02-20 |
HLA-DR binding peptides and their uses Grant 10,556,943 - Knutson , et al. Feb | 2020-02-11 |
Breast and ovarian cancer vaccines Grant 10,293,035 - Disis , et al. | 2019-05-21 |
Methods And Vaccines For Inducing Immune Responses To Multiple Different Mhc Molecules App 20190000948 - McCurry; Dustin B. ;   et al. | 2019-01-03 |
Methods And Materials For Expanding Antigen-specific T Cells In Culture App 20180245042 - Cohen; Peter A. ;   et al. | 2018-08-30 |
Hla-dr Binding Peptides And Their Uses App 20170342126 - Knutson; Keith L. ;   et al. | 2017-11-30 |
Cancer Vaccine Compositions And Methods Of Use Thereof App 20170283475 - DISIS; Mary L. ;   et al. | 2017-10-05 |
Methods Of Identifying Antigens For Vaccines App 20170266269 - DISIS; Mary L. ;   et al. | 2017-09-21 |
Breast And Ovarian Cancer Vaccines App 20170182137 - DISIS; Mary L. ;   et al. | 2017-06-29 |
Compositions And Methods For The Diagnosis And Treatment Of Breast Cancer App 20160209414 - Disis; Mary L. ;   et al. | 2016-07-21 |
Molecules and methods for treatment and detection of cancer Grant 9,060,961 - Disis , et al. June 23, 2 | 2015-06-23 |
Hla-dr Binding Peptides And Their Uses App 20140377340 - Knutson; Keith L. ;   et al. | 2014-12-25 |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 8,524,491 - Cheever , et al. September 3, 2 | 2013-09-03 |
Diagnostic panel of cancer antibodies and methods for use Grant 8,216,789 - Disis , et al. July 10, 2 | 2012-07-10 |
Hla-dr Binding Peptides And Their Uses App 20100310640 - Knutson; Keith L. ;   et al. | 2010-12-09 |
Molecules And Methods For Treatment And Detection Of Cancer App 20100092523 - Disis; Mary L. ;   et al. | 2010-04-15 |
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated App 20100087621 - Cheever; Martin A. ;   et al. | 2010-04-08 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,655,239 - Cheever , et al. February 2, 2 | 2010-02-02 |
COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED App 20100010075 - CHEEVER; Martin A. ;   et al. | 2010-01-14 |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,601,697 - Cheever , et al. October 13, 2 | 2009-10-13 |
Diagnostic Panel Of Cancer Antibodies And Methods For Use App 20090215091 - Disis; Mary L. ;   et al. | 2009-08-27 |
Surface receptor antigen vaccines Grant 7,547,681 - Scholler , et al. June 16, 2 | 2009-06-16 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated App 20080076904 - Cheever; Martin A. ;   et al. | 2008-03-27 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 7,247,703 - Cheever , et al. July 24, 2 | 2007-07-24 |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins App 20060008479 - Cheever; Martin A. ;   et al. | 2006-01-12 |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated Grant 6,953,573 - Cheever , et al. October 11, 2 | 2005-10-11 |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins Grant 6,942,862 - Cheever , et al. September 13, 2 | 2005-09-13 |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated App 20050191285 - Cheever, Martin A. ;   et al. | 2005-09-01 |
Surface receptor antigen vaccines App 20040219161 - Scholler, Nathalie B. ;   et al. | 2004-11-04 |
Surface receptor antigen vaccines Grant 6,734,172 - Scholler , et al. May 11, 2 | 2004-05-11 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated App 20040082758 - Cheever, Martin A. ;   et al. | 2004-04-29 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 6,664,370 - Cheever , et al. December 16, 2 | 2003-12-16 |
Surface Receptor Antigen Vaccines App 20030008342 - Scholler, Nathalie B. ;   et al. | 2003-01-09 |
Immune Reactivity To Her-2/neu Protein For Diagnosis And Treatment Of Malignancies In Which The Her-2/neu Oncogene Is Associated App 20020055614 - CHEEVER, MARTIN A ;   et al. | 2002-05-09 |
Methods And Compositions To Generate Immunity In Humans Against Self Tumor Antigens By Immunization With Homologous Foreign Proteins App 20020019331 - CHEEVER, MARTIN A ;   et al. | 2002-02-14 |
Therapeutic delivery using compounds self-assembled into high axial ratio microstructures Grant 6,180,114 - Yager , et al. January 30, 2 | 2001-01-30 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 5,876,712 - Cheever , et al. March 2, 1 | 1999-03-02 |
Methods for eliciting or enhancing reactivity to HER-2/neu protein Grant 5,869,445 - Cheever , et al. February 9, 1 | 1999-02-09 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated Grant 5,846,538 - Cheever , et al. December 8, 1 | 1998-12-08 |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated Grant 5,801,005 - Cheever , et al. September 1, 1 | 1998-09-01 |
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated Grant 5,726,023 - Cheever , et al. March 10, 1 | 1998-03-10 |